• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

    Cargill to Double Production of Tapioca Syrup

    Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences

    Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure

    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods

    Red Seaweed Digestive Supplement for Cattle Could Reduce Enteric Methane Emissions by 80%

    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients

    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

    Cargill to Double Production of Tapioca Syrup

    Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences

    Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Red Seaweed Digestive Supplement for Cattle Could Reduce Enteric Methane Emissions by 80%

    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults

    Vitamin Angels’ Mother’s Day Donation Campaign Raises Awareness for Maternal and Child Nutrition

    Bioiberica Forays into Two New Health Areas

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    Nutrition21, LLC

    Gencor

    KLK OLEO

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    Nutrition21, LLC

    Gencor

    KLK OLEO

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Demystifying the Regulatory Status of CBD

    The hype and the legal issues surrounding cannabinoids need context, and you probably need a lawyer.

    Demystifying the Regulatory Status of CBD
    Related CONTENT
    • Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    • FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    • HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    • James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation
    • Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    By Todd Harrison, Venable11.01.18
    With the explosion of interest in products that contain cannabidiol (CBD), now seems like the perfect time to discuss the regulatory status of cannabinoids. This column does not take a position on whether CBD or other cannabinoids should be permitted, from a policy perspective, to be marketed over-the-counter as dietary supplements. Rather, I am posing a series of questions intended to assist companies in determining whether it’s worth the business risk to market these products. So, here we go...

    Question 1: What laws control the use of CBD in dietary supplements?

    Answer: The Control Substance Act (CSA), The Federal Food, Drug, and Cosmetic Act (the Act), the Farm Act of 2014, and finally state laws. Understand, state laws that permit the marketing of CBD products may only pertain to products cultivated, grown. and manufactured within the state pursuant to a permit or license issued by the state. Put another way, a state may prohibit the sale of CBD and hemp extracts that are produced in other states.

    Question 2: Are CBD and other cannabinoids Schedule I controlled substances?

    Answer: The answer to this question turns on the definition of marijuana and whether it is an FDA-approved drug. More specifically, only CBD and cannabinoids that come from the non-resin portion of the plant, including the stalk and the seeds, are exempt from the definition of marijuana and therefore are not Schedule I controlled substances. FDA-approved drugs are Schedule V controlled substances. 

    Question 3: Doesn’t the Farm Act of 2014 essentially de-schedule hemp? 

    Answer: No, it does not. Indeed, the Farm Act of 2014 only permits the growing and propagation of hemp as part of a research project within a state. Even if one could argue that limited commercialization within a state permits the marketing of CBD dietary supplements, it would only apply to that state. For instance, you could not market a CBD dietary supplement that is from the flower or leaf of the plant in the state of Maryland unless the hemp was grown in Maryland pursuant to a permit issued by the state of Maryland. For some reason, this fact remains lost on the industry. Also, if it did allow for the interstate commercialization of hemp and hemp-derived products, the proposed language in the Farm Bill of 2018 de-scheduling hemp would be unnecessary. 

    Question 4: If the CBD in a product comes from the stalk or seed of hemp, can I market it as a dietary supplement or as an ingredient in food?

    Answer: I am not going to be drawn into a debate as to whether it is economically feasible to extract CBD from the stalk or seed of hemp. For our purposes here, we will presume that this statement is true. However, the only practical legal impact is that the product is not subject to the CSA. Similarly, if the source of CBD or other cannabinoids do not come from hemp or other cannabis cultivars, then it is not subject to the CSA.

    However, one must also analyze it under the Federal Food, Drug, and Cosmetic Act. Under Section 201(ff)(3)(B), if the article is marketed as a dietary supplement, it must have been on the marketplace before FDA authorized its investigation as a new drug and substantial clinical trials have been undertaken. This means that CBD and other cannabinoids had to have been marketed prior to GW Pharmaceuticals’ IND for Epidiolex and the start of the clinical trials, which happened in 2007. FDA is on the record in numerous warning letters that it is unaware of CBD’s use in a dietary supplement prior to the IND and institution of clinical trials. 

    Similarly, Section 301(ll) of the Act, does not permit its addition into food if it was not marketed as an article in food prior to the institution of substantial clinical trials. Thus, a Generally Recognized As Safe (GRAS) document produced 11 years after the fact has no legal weight if it cannot be established that CBD was marketed prior to the clinical trials. 

    With that said, Section 301(ll)(2) does allow a company or industry to petition FDA to permit its use in food; so the door is open. The question is whether the industry wants to attempt to petition the agency to permit its marketing in food, which by default would also include dietary supplements. 

    It is important to note the article that was authorized for investigation and subsequent clinical trials is CBD. Cannabidiolic acid (CBDA) and other cannabinoids have not been authorized for investigation or subject to clinical trials. Thus, there is an opening here to market CBDA and the other cannabinoids once the controlled substance issue is straightened out.

    Finally, there are defenses to the preclusion provisions, however, you will need to seek the advice of legal counsel to determine how strong these arguments are, as I do not have the space in this column to go through all the legal arguments. Some of them have merit and pass the laugh test while others are highly suspect. Regardless, this requires you to work through counsel to determine the strength of those arguments. 

    Question 5: Everyone is marketing CBD so it must be legal, right?

    Answer: Law enforcement and regulatory agencies routinely permit the marketing of products that may otherwise be violative through enforcement discretion. Here, I agree, the DEA does not seem very interested and FDA simply needs to make a decision to permit its marketing or enforce. However, while it is high enough on its priority list to merit warning letters, it is not so high (pun intended) to warrant enforcement action, but that is simply reading the tea leaves. 

    With that said, here is something that no one talks about and people refuse to deal with: domestic credit card processors will not knowingly process for companies that are selling CBD because of concerns regarding its controlled substance status. Thus, many of the companies that are processing are not informing the processor that it is for CBD products, which may itself create an entirely different set of legal issues; or they are using expensive offshore processors, which come at a premium. Of course, this is another issue that is simply not discussed but must be factored into any decision to market CBD products.

    Question 6: When the Farm Bill of 2018 is passed won’t it take care of everything?

    Answer: By the time this column publishes, the Farm Bill of 2018 may have passed and it may include language about hemp. However, the Farm Bill of 2018 only de-schedules hemp and products derived from hemp; it does not impact the FFDCA analysis because the language (as it stands as of this writing) makes it clear that nothing within the bill would modify or preempt the FFDCA.

    Question 7: What about topical products?

    Answer: Presuming you can overcome the CSA, the preclusion provisions of the FFDCA do not apply to topical cosmetic products as along as impermissible drug claims are not being made. 
    I hope this column at least places the issues surrounding CBD and cannabinoids in the appropriate context. I am hopeful that in the near future the CSA issue will be placed to rest with the Farm Bill of 2018. I am also hopeful that at some point someone with strong safety data comes forward to request permission from FDA to sell CBD in foods and dietary supplements, as there is a reason we have an endocannabinoid system. Providing it with nutritional support would have significant health benefits completely unrelated to treating rare epileptic seizures.

    As I have stated so many times in columns and speeches, we need to stop treating everything as a binary choice between being diseased or being healthy. In fact, “healthy” encompasses a wide spectrum. Indeed, osteoarthritis, while classified as a disease, is in fact normal wear and tear that we all experience. Yet people are denied access to products that may help them and instead are prescribed opioids; and we have seen what that has wrought on society.

    Companies in the natural product/dietary supplement industry often wonder why regulators don’t seem to trust the industry. However, rushing ingredients into the market on questionable legal theories without following the regulatory process is one reason for this distrust. I understand frustration when it comes to claims, but cavalier attitudes toward regulatory procedures of ingredients pose a more long-term threat to the industry.

    Still, it’s challenging when FDA seems more concerned with “disease” claims related to supporting fertility and age-related joint pain rather than enforcing the dietary ingredient provisions of the Act. But that is simply my take about ingredients in general, and not on CBD in particular.


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling, and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Functional Food
    • Fertility
    • Dietary Supplement
    • Tea
    Suggested For You
    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation
    Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    Dietary Supplement Listing Bill Introduced in Senate Dietary Supplement Listing Bill Introduced in Senate
    FDA Issues NAC Enforcement Discretion Guidance FDA Issues NAC Enforcement Discretion Guidance
    Steve Mister and Tara Falsani to Co-Chair ACI/CRN Dietary Supplements Forum Steve Mister and Tara Falsani to Co-Chair ACI/CRN Dietary Supplements Forum
    FDA Seeks DSHEA Amendments FDA Seeks DSHEA Amendments
    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research Beyond CBD: Cannabis Compounds Warrant Recognition and More Research
    Wegmans to Debut Dietary Supplements Verification Program Wegmans to Debut Dietary Supplements Verification Program
    The Nuts and Bolts of FDA’s 2023 Budget Request The Nuts and Bolts of FDA’s 2023 Budget Request
    Keeping Score: CBD in Sports Keeping Score: CBD in Sports
    Lead the Hemp and CBD Market with Science Lead the Hemp and CBD Market with Science

    Related Content

    • Herbs & Botanicals | Quality & Safety | Testing
      Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients

      Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients

      The report concluded CBG, CBN, and CBC test articles were non-mutagenic, non-clastogenic, and non-genotoxic.
      05.06.22

    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations
      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      This marked the first time the agency took enforcement action against a delta-8 THC-containing product.
      05.04.22

    • HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe

      HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe

      Several botanicals and the clinical trials backing them will be featured.
      05.04.22


    • Antioxidants | Herbs & Botanicals | Research
      James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation

      James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation

      The chief scientific officer for Layn Natural Ingredients has over 30 years of experience in the natural products and nutraceutical industry.
      By Sheldon Baker, CEO of Baker Dillon Group 05.03.22

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Natural/Organic | Regulations | World Markets
      Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing

      Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing

      Marc Ross discusses how companies getting in front of ESG are well-positioned to win investors, talent, and customers.
      By Sheldon Baker, CEO Baker Dillon Group LLC 05.03.22

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Indena’s Meriva Curcumin Supplement May Benefit Kidney Function
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Test On Hydrolyzed Collagen Shows Resoundingly High Bioavailability | Nutraceuticals World
      • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity | Nutraceuticals World
      Breaking News
      • Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
      • Cargill to Double Production of Tapioca Syrup
      • Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences
      • Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure
      • Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
      Cargill to Double Production of Tapioca Syrup
      Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences
      Coatings World

      Latest Breaking News From Coatings World

      Indorama Ventures Achieves Record 1Q22 Performance
      Lan Deng Joins The ChemQuest Group as Director
      Benjamin Moore Receives Two J.D. Power Awards
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—May 14
      Teleflex Launches UroLift 2 System and UroLift ATC System in the U.S.
      ENDRA Life Sciences Achieves ISO 13485 Recertification
      Contract Pharma

      Latest Breaking News From Contract Pharma

      LOTTE to Purchase BMS East Syracuse NY Manufacturing Facility
      Bora Pharmaceuticals Acquires CDMO Assets from Eden Biologics
      Cytiva Opening New Facility in Switzerland
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      5 Packaging Execs Inducted into NJPEC Hall of Fame
      Nautica Unveils New Eco-Conscious, Alcohol-Free Fragrance
      Sigma Beauty Launches Clean Blushes, Bronzers and Highlighters
      Happi

      Latest Breaking News From Happi

      Proposed Senate FDA Legislation Includes Cosmetics Reform
      China Beauty Sales Slow; Blueland Enters Personal Care Category; Lady Gaga’s Cosmetics Relaunch
      Method For Stabilizing Retinoic Acid Precursors
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: INX’s New VC Fund, Flint Group and Siegwerk Lead This Week’s News
      The 2022 CPIPC Golf Outing Set for June 22
      NUtec’s NUbis Bulk Ink System Enables Continuous Printing
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      LemuGroup hosting Open House, Lynn Perenic honored and more
      PCMC and Hudson-Sharp assist Aspen Press & Packaging
      LemuGroup prepares for Open House in Spain
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Ontex Confirms Possibility of Attindas Deal, Purell Launches New Wipes & More
      TSG Finishing Starts Modernization Project
      Berry Global Sets New Target to Reduce Scope 3 Emissions
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—May 14
      Steven Haddad Joins Extremity Medical as Chief Clinical Officer
      FDA OKs Accelus' FlareHawk TiHawk11 Interbodies
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Graphene Flagship Launches Its First Customizable Wafer Run
      CCL Industries Announces 1Q 2022 First Quarter Results
      LG Display Showcases Innovative OLED Technology at SID 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login